Philippe Kadhel

Papers

Total Citations

H-Index

About

Dr. Philippe Kadhel is a prominent figure in gynecologic oncology, with a focused research agenda on improving outcomes for patients with advanced ovarian cancer. His work critically addresses one of the field’s most challenging clinical dilemmas: the management of recurrent disease. Dr. Kadhel’s major contribution lies in evaluating the role of secondary complete cytoreductive surgery, demonstrating its growing legitimacy as a treatment strategy for patients with late relapse. His landmark 2019 paper, which has garnered 5 citations, argues that surgery, when compared to chemotherapy alone, offers a tangible survival benefit for carefully selected patients, directly confronting the reality that three-quarters of advanced ovarian cancer patients will experience relapse despite optimal initial therapy. By championing this surgical approach, Dr. Kadhel has helped shift the treatment paradigm, framing relapse not as an endpoint but as a new opportunity for aggressive, life-extending intervention. His work is essential reading for any researcher or clinician seeking to understand the evolving surgical management of recurrent ovarian cancer and the ongoing effort to transform a public health issue into a manageable chronic condition.